Marshall Wace
ZEPP

Marshall Wace’s Zepp Health ZEPP Stock Holding History

Marshall Wace’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-62,569
Closed -$2.86M – 3576
2025
Q3 		$2.86M Buy
+62,569
New +$1.9M ﹤0.01% 1440
2023
Q1 		– Sell
-11,682
Closed -$67.8K – 3167
2022
Q4 		$67.8K Sell
11,682
-29,111
-71% -$156K ﹤0.01% 2826
2022
Q3 		$222K Sell
40,793
-14,693
-26% -$106K ﹤0.01% 3056
2022
Q2 		$410K Buy
55,486
+8,508
+18% +$78.3K ﹤0.01% 2888
2022
Q1 		$543K Buy
+46,978
New +$759K ﹤0.01% 2738
2021
Q2 		– Sell
-11,227
Closed -$484K – 3170
2021
Q1 		$484K Buy
+11,227
New +$652K ﹤0.01% 1954
2020
Q1 		– Sell
-757
Closed -$36K – 2125
2019
Q4 		$36K Sell
757
-935
-55% -$39.2K ﹤0.01% 1570
2019
Q3 		$67K Sell
1,692
-64,408
-97% -$2.7M ﹤0.01% 1441
2019
Q2 		$2.64M Buy
66,100
+60,206
+1,021% +$2.51M 0.02% 691
2019
Q1 		$309K Buy
5,894
+5,741
+3,752% +$310K ﹤0.01% 1256
2018
Q4 		$6K Buy
+153
New +$6.01K ﹤0.01% 1542

Other funds holding ZEPP

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
MM
Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Marshall Wace's ZEPP Position: Q4 2025 in Review

Marshall Wace sold out of Zepp Health (ZEPP) in Q4 2025, closing a stake of 62,569 shares — an estimated $2.86M sold.

Marshall Wace first reported a position in ZEPP in Q4 2018 and held it in 11 quarters. The position peaked at $2.86M in Q3 2025. 38 funds tracked by Wall St. Rank hold ZEPP as of Q4 2025.

  • Marshall Wace reported no remaining Zepp Health position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 62,569 Zepp Health shares in Q4 2025, an estimated $2.86M.
  • Marshall Wace first reported a position in Zepp Health in Q4 2018 and held it in 11 quarters.
  • Marshall Wace's Zepp Health position peaked at $2.86M in Q3 2025.
  • 38 funds tracked by Wall St. Rank held Zepp Health as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.